Genetic Technologies Limited
GNTLF
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -2.74% | -61.51% | |||
| Total Revenue | -2.74% | -91.23% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -2.74% | -84.94% | |||
| SG&A Expenses | -2.74% | -79.00% | |||
| Depreciation & Amortization | -2.79% | -74.34% | |||
| Other Operating Expenses | -2.72% | -68.66% | |||
| Total Operating Expenses | -2.74% | -82.02% | |||
| Operating Income | 2.76% | 73.87% | |||
| Income Before Tax | 2.75% | 44.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.75% | 44.55% | |||
| Earnings from Discontinued Operations | 2.74% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.75% | 25.77% | |||
| EBIT | 2.76% | 73.87% | |||
| EBITDA | 2.74% | 73.85% | |||
| EPS Basic | 3.16% | 23.39% | |||
| Normalized Basic EPS | 4.76% | 72.73% | |||
| EPS Diluted | 3.16% | 23.39% | |||
| Normalized Diluted EPS | 4.76% | 72.73% | |||
| Average Basic Shares Outstanding | 0.00% | -3.19% | |||
| Average Diluted Shares Outstanding | 0.00% | -3.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||